Categories: India

BRIEF-Xoma Royalty And Lava Therapeutics Announce Amendment To Purchase Agreement

Oct 17 (Reuters) – XOMA ROYALTY: * XOMA ROYALTY AND LAVA THERAPEUTICS ANNOUNCE AMENDMENT TO PURCHASE AGREEMENT * XOMA ROYALTY CORP: LAVA SHAREHOLDERS WHO TENDER THEIR SHARES WILL NOW RECEIVE AN INITIAL CASH AMOUNT PER SHARE OF $1.04 * XOMA ROYALTY CORP: AMENDMENT TO AGREEMENT WITH LAVA INCLUDES UPDATED CVR TERMS FOR TENDER OFFER Source text: Further company coverage:

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

Indianews Syndication

Recent Posts

Kennametal India’s Revenue Grows by 39% in the Quarter Ended March 2026

Bengaluru (Karnataka) [India], May 11: Kennametal India Limited (KIL) reported revenues of ₹4031 million for…

9 hours ago